Stemsation International Stock Price, News & Analysis
Company Description
Stemsation International (OTC Link: STSN) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $5.6M.
STSN stock has declined 37.9% over the past year. Shares last traded at $0.0036.
This page provides a comprehensive overview of STSN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Stemsation International (STSN) stock last traded at $0.0036. Over the past 12 months, the stock has lost 37.9%. At a market capitalization of $5.6M, STSN is classified as a micro-cap stock with approximately 620.5M shares outstanding.
Latest News
Stemsation International has 8 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition. View all STSN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Stemsation International (STSN) currently stands at 10.4 thousand shares, up 1000.0% from the previous reporting period. Over the past 12 months, short interest has decreased by 67.6%.
Days to Cover History
Days to cover for Stemsation International (STSN) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
STSN Company Profile & Sector Positioning
Stemsation International (STSN) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing STSN often look at related companies in the same sector, including Cv Sciences (CVSI), Marijuana Inc. (MAJI), Cannabis Bioscience International Holdings Inc (CBIH), StateHouse Holdings Inc (STHZF), and Crescita Therape (CRRTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate STSN's relative position within its industry.